Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2012
12/20/2012US20120322880 Pharmaceutical Formulations of Modafinil
12/20/2012US20120322879 Use of ci-994 and dinaline for the treatment of memory/cognition and anxiety disorders
12/20/2012US20120322878 Polycationic Compounds And Uses Thereof
12/20/2012US20120322877 (bis)urea and (bis)thiorea compounds as eipgenic modulators of lysine-specific demethylase 1 and methods of treating disorders
12/20/2012US20120322875 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
12/20/2012US20120322874 Pharmaceutical Uses
12/20/2012US20120322871 Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives
12/20/2012US20120322868 Food products, preparation, and therapeutic methods
12/20/2012US20120322867 Methods of Treating an Overweight or Obese Subject
12/20/2012US20120322866 Composition comprising (-)-delta9-trans-tetrahydrocannabinol
12/20/2012US20120322863 Prevention of and countermeasures against mitochondrial disease
12/20/2012US20120322862 Aptamers to 4-1BB and Their Use in Treating Diseases and Disorders
12/20/2012US20120322861 Compositions and Methods for Treating Diseases
12/20/2012US20120322860 Aptamer therapeutics useful in the treatment of complement-related disorders
12/20/2012US20120322859 MicroRNA Fingerprints During Human Megakaryocytopoiesis
12/20/2012US20120322858 Compositions and Methods for Inhibiting Expression of a Mutant Gene
12/20/2012US20120322857 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells
12/20/2012US20120322856 Method for Promoting Angiogenesis, Vascularization, or Vessel Repair or for the Inhibiting Tumor Angiogenesis
12/20/2012US20120322855 Duplex Oligonucleotide Complexes and Methods for Gene Silencing by RNA Interference
12/20/2012US20120322854 Regulation of macrophage activation using mir-125b
12/20/2012US20120322853 Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene
12/20/2012US20120322852 SMNdelta7 Degron: Novel Compositions and Methods of Use
12/20/2012US20120322851 Oral delivery of therapeutically effective lna oligonucleotides
12/20/2012US20120322850 Trpm-2 antisense therapy
12/20/2012US20120322848 Lna oligonucleotides and the treatment of cancer
12/20/2012US20120322847 ANTISENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING ssRNA VIRAL INFECTION
12/20/2012US20120322846 METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF SINGLE AND DOUBLE BLUNT-ENDED siRNA
12/20/2012US20120322845 Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine
12/20/2012US20120322844 Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety
12/20/2012US20120322843 Genotype specific methods for treating human subjects using 4-methylpyrazole
12/20/2012US20120322842 Heterocycyl-substituted-alkylaminophenyl derivatives, their preparation and use as medicaments
12/20/2012US20120322841 Aldosterone Synthase Inhibitor
12/20/2012US20120322840 Transdermally Absorbable Preparation Containing Basic Anti-Inflammatory Analgesic
12/20/2012US20120322838 Epothilone Compounds, Preparation Method and Use Thereof
12/20/2012US20120322837 Amide compound and medicinal use thereof
12/20/2012US20120322836 Pharmaceutical compositions and methods for stabilizing the same
12/20/2012US20120322835 Pharmaceutical compositions and methods for producing low impurity concentrations of the same
12/20/2012US20120322834 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities
12/20/2012US20120322832 Nicotinic attenuation of cns inflammation and autoimmunity
12/20/2012US20120322831 Compositions for reducing ab 42 production and their use in treating alzheimer's disease (ad)
12/20/2012US20120322830 Cyclourea Compounds as Calcium Channel Blockers
12/20/2012US20120322829 Use of a dipyridyl compound for treating rosacea
12/20/2012US20120322828 Methods for controlling pain in equines using a transdermal solution of fentanyl
12/20/2012US20120322827 Compounds and methods
12/20/2012US20120322826 5-ht4 receptor agonists for the treatment of dementia
12/20/2012US20120322825 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
12/20/2012US20120322824 Cocaine Antagonist/Antidepressant Pharmaceutical Preparations
12/20/2012US20120322823 Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
12/20/2012US20120322822 Composition containing cinchonine as an active ingredient for preventing and treating obesity, dyslipidemia, fatty liver, or insulin resistance syndrome
12/20/2012US20120322821 Ghrelin receptor agonist for treatment of cachexia
12/20/2012US20120322820 Methods to inhibit tumor cell growth by using proton pump inhibitors
12/20/2012US20120322819 Compound containing a novel 4-alkoxypyrimidine structure and medicine containing same
12/20/2012US20120322818 Phycotoxins and uses thereof
12/20/2012US20120322817 Combination
12/20/2012US20120322816 Rutaecarpine derivatives for activating cyp1a2 in a subject
12/20/2012US20120322815 Pharmaceutical composition containing a3 adenosine receptor agonist
12/20/2012US20120322814 Methods of inhibiting ire1
12/20/2012US20120322813 Rutaecarpine derivatives for treating caffeine toxicity
12/20/2012US20120322812 Rutaecarpine derivatives for treating insomnia
12/20/2012US20120322811 Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophrenia
12/20/2012US20120322810 New salts
12/20/2012US20120322809 Substituted oxindole derivatives and their use as vasopressin receptor ligands
12/20/2012US20120322808 Alpha 4 Beta 2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
12/20/2012US20120322807 Stat3/5 activation inhibitor
12/20/2012US20120322806 Quinoxalinedione derivatives
12/20/2012US20120322805 Pharmaceutical compositions of semi-ordered drugs and polymers
12/20/2012US20120322804 N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
12/20/2012US20120322803 Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
12/20/2012US20120322802 Novel 2, 4-pyrimidine derivatives and use thereof
12/20/2012US20120322801 Heterocyclic amides as rock inhibitors
12/20/2012US20120322800 Sepiapterin Reductase Inhibitors For The Treatment of Pain
12/20/2012US20120322799 Deuterated compounds useful for treating neurodegenerative diseases
12/20/2012US20120322798 Modulators of ATP-Binding Cassette Transporters
12/20/2012US20120322797 Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents
12/20/2012US20120322796 Benzocycloheptane and benzoxepine derivatives
12/20/2012US20120322795 Biarylamide inhibitors of leukotriene production
12/20/2012US20120322794 Treatment tool and method of gradual withdrawal from benzodiazepine dependency
12/20/2012US20120322793 Protein kinase inhibitors
12/20/2012US20120322792 Method and Compositions for Treating Cancer and Related Methods
12/20/2012US20120322791 PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
12/20/2012US20120322790 Pyrazolopiperidine Compounds As CCR1 Receptor Antagonists
12/20/2012US20120322789 Organic compounds
12/20/2012US20120322788 Compouds
12/20/2012US20120322787 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
12/20/2012US20120322786 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
12/20/2012US20120322785 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
12/20/2012US20120322784 Compounds, pharmaceutical compositions and uses thereof
12/20/2012US20120322783 Tumescent antibiotic solution
12/20/2012US20120322782 Veterinary compositions
12/20/2012US20120322781 Pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties
12/20/2012US20120322780 Steroidal compositions
12/20/2012US20120322779 Estriol Therapy for Autoimmune and Neurodegenerative Diseases and Disorders
12/20/2012US20120322778 Pharmaceutical compositions
12/20/2012US20120322777 Oral Contraceptives to Prevent Pregnancy and Diminish Premenstrual Symptomatology
12/20/2012US20120322776 Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
12/20/2012US20120322775 3-Desoxy-2-Methylene-19-Nor-Vitamin D Analogs and Their Uses
12/20/2012US20120322774 Chocolate having cholecalciferol and method for forming
12/20/2012US20120322773 Materials and methods for treatment of disorders associated with oxidative stress
12/20/2012US20120322772 Substituted imidazopyrimidines and triazolopyrimidines
12/20/2012US20120322770 Therapeutic compounds for blocking dna synthesis of pox viruses
1 ... 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 ... 7860